Clinical Trials Browser

Phase 1/2 × Arginine × Tumor-Agnostic × Clear all

NCT02844387 2016-07-28

Supplementation of L-arginine in Patients With Non-resectable Brain Metastases

Phase 1/2 Completed

Neoplasms